title: Cases: Cocaine adulterant linked to neutropenia.
authors.affiliation: Department of Pharmacy, Chilliwack General Hospital, Chilliwack, BC. matthew.wiens@fraserhealth.ca
authors.forename: Matthew O
authors.initials: MO
authors.lastname: Wiens
authors.forename: Wai Kon
authors.initials: WK
authors.lastname: Son
authors.forename: Colin
authors.initials: C
authors.lastname: Ross
authors.forename: Michael
authors.initials: M
authors.lastname: Hayden
authors.forename: Bruce
authors.initials: B
authors.lastname: Carleton
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D019970:Cocaine-Related Disorders / Q000150:complications*; D004340:Drug Contamination; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007978:Levamisole / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D018501:Antirheumatic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D007978:Levamisole; D000069585:Filgrastim